KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Net Margin: 2010-2025

Historic Net Margin for Pacira BioSciences (PCRX) over the last 16 years, with Sep 2025 value amounting to 3.03%.

  • Pacira BioSciences' Net Margin rose 8813.00% to 3.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.99%, marking a year-over-year increase of 1605.00%. This contributed to the annual value of -14.20% for FY2024, which is 2042.00% down from last year.
  • Pacira BioSciences' Net Margin amounted to 3.03% in Q3 2025, which was up 213.06% from -2.68% recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Net Margin peaked at 15.20% during Q2 2023, and registered a low of -85.11% during Q3 2024.
  • Moreover, its 3-year median value for Net Margin was 5.37% (2024), whereas its average is -3.09%.
  • As far as peak fluctuations go, Pacira BioSciences' Net Margin crashed by 9,695bps in 2021, and later spiked by 8,813bps in 2025.
  • Over the past 5 years, Pacira BioSciences' Net Margin (Quarterly) stood at -3.22% in 2021, then tumbled by 265bps to -5.87% in 2022, then surged by 1,960bps to 13.72% in 2023, then crashed by 516bps to 8.57% in 2024, then soared by 8,813bps to 3.03% in 2025.
  • Its Net Margin stands at 3.03% for Q3 2025, versus -2.68% for Q2 2025 and 2.85% for Q1 2025.